A	O
Facile	O
Strategy	B:C0035171
to	O
Prepare	O
an	O
Enzyme	O
-	O
Responsive	O
Mussel	O
Mimetic	O
Coating	O
for	O
Drug	O
Delivery	I:C1881966
Based	O
on	O
Mesoporous	O
Silica	I:C0037098
Nanoparticles	O
.	O

A	O
Facile	O
Strategy	O
to	O
Prepare	O
an	O
Enzyme	B:C0014442
-	O
Responsive	O
Mussel	O
Mimetic	O
Coating	O
for	O
Drug	O
Delivery	I:C1881966
Based	O
on	O
Mesoporous	O
Silica	I:C0037098
Nanoparticles	O
.	O

A	O
Facile	O
Strategy	O
to	O
Prepare	O
an	O
Enzyme	O
-	O
Responsive	O
Mussel	B:C0026871
Mimetic	O
Coating	O
for	O
Drug	O
Delivery	I:C1881966
Based	O
on	O
Mesoporous	O
Silica	I:C0037098
Nanoparticles	O
.	O

A	O
Facile	O
Strategy	O
to	O
Prepare	O
an	O
Enzyme	O
-	O
Responsive	O
Mussel	O
Mimetic	O
Coating	O
for	O
Drug	B:C1881966
Delivery	I:C1881966
Based	O
on	O
Mesoporous	O
Silica	I:C0037098
Nanoparticles	O
.	O

A	O
Facile	O
Strategy	O
to	O
Prepare	O
an	O
Enzyme	O
-	O
Responsive	O
Mussel	O
Mimetic	O
Coating	O
for	O
Drug	O
Delivery	I:C1881966
Based	O
on	O
Mesoporous	B:C0037098
Silica	I:C0037098
Nanoparticles	O
.	O

Surface	B:C0205148
functional	O
mesoporous	O
silica	I:C0037098
nanoparticles	O
(	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
)	O
have	O
been	O
widely	O
used	O
as	O
promosing	O
materials	O
for	O
drug	O
delivery	I:C1881966
.	O

Surface	O
functional	O
mesoporous	B:C0037098
silica	I:C0037098
nanoparticles	O
(	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
)	O
have	O
been	O
widely	O
used	O
as	O
promosing	O
materials	O
for	O
drug	O
delivery	I:C1881966
.	O

Surface	O
functional	O
mesoporous	O
silica	I:C0037098
nanoparticles	O
(	O
mesoporous	B:C0037098
silica	I:C0037098
nanoparticles	I:C0037098
)	O
have	O
been	O
widely	O
used	O
as	O
promosing	O
materials	O
for	O
drug	O
delivery	I:C1881966
.	O

Surface	O
functional	O
mesoporous	O
silica	I:C0037098
nanoparticles	O
(	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
)	O
have	O
been	O
widely	O
used	O
as	O
promosing	O
materials	B:C0005479
for	O
drug	O
delivery	I:C1881966
.	O

Surface	O
functional	O
mesoporous	O
silica	I:C0037098
nanoparticles	O
(	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
)	O
have	O
been	O
widely	O
used	O
as	O
promosing	O
materials	O
for	O
drug	B:C1881966
delivery	I:C1881966
.	O

Herein	O
,	O
we	O
reported	O
a	O
facile	O
strategy	B:C0035171
to	O
construct	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
coated	O
by	O
enzyme	O
-	O
resposive	O
polylysine	O
-	O
dopamine	O
(	O
polylysine	O
-	I:C0013030
dopamine	I:C0013030
)	O
films	O
through	O
self	O
-	O
polymerization	O
of	O
dopamine	O
derivative	O
lysine	O
-	O
dopamine	O
,	O
in	O
which	O
the	O
drug	O
could	O
be	O
loaded	O
and	O
delivered	O
efficiently	O
.	O

Herein	O
,	O
we	O
reported	O
a	O
facile	O
strategy	O
to	O
construct	O
mesoporous	B:C0037098
silica	I:C0037098
nanoparticles	I:C0037098
coated	O
by	O
enzyme	O
-	O
resposive	O
polylysine	O
-	O
dopamine	O
(	O
polylysine	O
-	I:C0013030
dopamine	I:C0013030
)	O
films	O
through	O
self	O
-	O
polymerization	O
of	O
dopamine	O
derivative	O
lysine	O
-	O
dopamine	O
,	O
in	O
which	O
the	O
drug	O
could	O
be	O
loaded	O
and	O
delivered	O
efficiently	O
.	O

Herein	O
,	O
we	O
reported	O
a	O
facile	O
strategy	O
to	O
construct	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
coated	O
by	O
enzyme	B:C0014442
-	O
resposive	O
polylysine	O
-	O
dopamine	O
(	O
polylysine	O
-	I:C0013030
dopamine	I:C0013030
)	O
films	O
through	O
self	O
-	O
polymerization	O
of	O
dopamine	O
derivative	O
lysine	O
-	O
dopamine	O
,	O
in	O
which	O
the	O
drug	O
could	O
be	O
loaded	O
and	O
delivered	O
efficiently	O
.	O

Herein	O
,	O
we	O
reported	O
a	O
facile	O
strategy	O
to	O
construct	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
coated	O
by	O
enzyme	O
-	O
resposive	O
polylysine	B:C0032518
-	O
dopamine	O
(	O
polylysine	O
-	I:C0013030
dopamine	I:C0013030
)	O
films	O
through	O
self	O
-	O
polymerization	O
of	O
dopamine	O
derivative	O
lysine	O
-	O
dopamine	O
,	O
in	O
which	O
the	O
drug	O
could	O
be	O
loaded	O
and	O
delivered	O
efficiently	O
.	O

Herein	O
,	O
we	O
reported	O
a	O
facile	O
strategy	O
to	O
construct	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
coated	O
by	O
enzyme	O
-	O
resposive	O
polylysine	O
-	O
dopamine	B:C0013030
(	O
polylysine	O
-	I:C0013030
dopamine	I:C0013030
)	O
films	O
through	O
self	O
-	O
polymerization	O
of	O
dopamine	O
derivative	O
lysine	O
-	O
dopamine	O
,	O
in	O
which	O
the	O
drug	O
could	O
be	O
loaded	O
and	O
delivered	O
efficiently	O
.	O

Herein	O
,	O
we	O
reported	O
a	O
facile	O
strategy	O
to	O
construct	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
coated	O
by	O
enzyme	O
-	O
resposive	O
polylysine	O
-	O
dopamine	O
(	O
polylysine	B:C0013030
-	I:C0013030
dopamine	I:C0013030
)	O
films	O
through	O
self	O
-	O
polymerization	O
of	O
dopamine	O
derivative	O
lysine	O
-	O
dopamine	O
,	O
in	O
which	O
the	O
drug	O
could	O
be	O
loaded	O
and	O
delivered	O
efficiently	O
.	O

Herein	O
,	O
we	O
reported	O
a	O
facile	O
strategy	O
to	O
construct	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
coated	O
by	O
enzyme	O
-	O
resposive	O
polylysine	O
-	O
dopamine	O
(	O
polylysine	O
-	I:C0013030
dopamine	I:C0013030
)	O
films	O
through	O
self	O
-	O
polymerization	O
of	O
dopamine	B:C0013030
derivative	O
lysine	O
-	O
dopamine	O
,	O
in	O
which	O
the	O
drug	O
could	O
be	O
loaded	O
and	O
delivered	O
efficiently	O
.	O

Herein	O
,	O
we	O
reported	O
a	O
facile	O
strategy	O
to	O
construct	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
coated	O
by	O
enzyme	O
-	O
resposive	O
polylysine	O
-	O
dopamine	O
(	O
polylysine	O
-	I:C0013030
dopamine	I:C0013030
)	O
films	O
through	O
self	O
-	O
polymerization	O
of	O
dopamine	O
derivative	O
lysine	B:C0024337
-	O
dopamine	O
,	O
in	O
which	O
the	O
drug	O
could	O
be	O
loaded	O
and	O
delivered	O
efficiently	O
.	O

Herein	O
,	O
we	O
reported	O
a	O
facile	O
strategy	O
to	O
construct	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
coated	O
by	O
enzyme	O
-	O
resposive	O
polylysine	O
-	O
dopamine	O
(	O
polylysine	O
-	I:C0013030
dopamine	I:C0013030
)	O
films	O
through	O
self	O
-	O
polymerization	O
of	O
dopamine	O
derivative	O
lysine	O
-	O
dopamine	B:C0013030
,	O
in	O
which	O
the	O
drug	O
could	O
be	O
loaded	O
and	O
delivered	O
efficiently	O
.	O

Herein	O
,	O
we	O
reported	O
a	O
facile	O
strategy	O
to	O
construct	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
coated	O
by	O
enzyme	O
-	O
resposive	O
polylysine	O
-	O
dopamine	O
(	O
polylysine	O
-	I:C0013030
dopamine	I:C0013030
)	O
films	O
through	O
self	O
-	O
polymerization	O
of	O
dopamine	O
derivative	O
lysine	O
-	O
dopamine	O
,	O
in	O
which	O
the	O
drug	B:C0013227
could	O
be	O
loaded	O
and	O
delivered	O
efficiently	O
.	O

In	O
detail	O
,	O
RhB	B:C0073194
or	O
DOX	O
was	O
used	O
as	O
a	O
drug	O
model	O
and	O
loaded	O
in	O
functional	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
via	O
a	O
one	O
-	O
pot	O
procedure	O
among	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
,	O
drug	O
,	O
and	O
lysine	O
-	O
dopamine	O
(	O
lysine	O
-	I:C0013030
dopamine	I:C0013030
)	O
under	O
basic	O
conditions	O
.	O

In	O
detail	O
,	O
RhB	O
or	O
DOX	B:C0013089
was	O
used	O
as	O
a	O
drug	O
model	O
and	O
loaded	O
in	O
functional	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
via	O
a	O
one	O
-	O
pot	O
procedure	O
among	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
,	O
drug	O
,	O
and	O
lysine	O
-	O
dopamine	O
(	O
lysine	O
-	I:C0013030
dopamine	I:C0013030
)	O
under	O
basic	O
conditions	O
.	O

In	O
detail	O
,	O
RhB	O
or	O
DOX	O
was	O
used	O
as	O
a	O
drug	B:C1254351
model	O
and	O
loaded	O
in	O
functional	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
via	O
a	O
one	O
-	O
pot	O
procedure	O
among	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
,	O
drug	O
,	O
and	O
lysine	O
-	O
dopamine	O
(	O
lysine	O
-	I:C0013030
dopamine	I:C0013030
)	O
under	O
basic	O
conditions	O
.	O

In	O
detail	O
,	O
RhB	O
or	O
DOX	O
was	O
used	O
as	O
a	O
drug	O
model	B:C1515654
and	O
loaded	O
in	O
functional	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
via	O
a	O
one	O
-	O
pot	O
procedure	O
among	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
,	O
drug	O
,	O
and	O
lysine	O
-	O
dopamine	O
(	O
lysine	O
-	I:C0013030
dopamine	I:C0013030
)	O
under	O
basic	O
conditions	O
.	O

In	O
detail	O
,	O
RhB	O
or	O
DOX	O
was	O
used	O
as	O
a	O
drug	O
model	O
and	O
loaded	O
in	O
functional	O
mesoporous	B:C0037098
silica	I:C0037098
nanoparticles	I:C0037098
via	O
a	O
one	O
-	O
pot	O
procedure	O
among	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
,	O
drug	O
,	O
and	O
lysine	O
-	O
dopamine	O
(	O
lysine	O
-	I:C0013030
dopamine	I:C0013030
)	O
under	O
basic	O
conditions	O
.	O

In	O
detail	O
,	O
RhB	O
or	O
DOX	O
was	O
used	O
as	O
a	O
drug	O
model	O
and	O
loaded	O
in	O
functional	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
via	O
a	O
one	O
-	O
pot	O
procedure	O
among	O
mesoporous	B:C0037098
silica	I:C0037098
nanoparticles	I:C0037098
,	O
drug	O
,	O
and	O
lysine	O
-	O
dopamine	O
(	O
lysine	O
-	I:C0013030
dopamine	I:C0013030
)	O
under	O
basic	O
conditions	O
.	O

In	O
detail	O
,	O
RhB	O
or	O
DOX	O
was	O
used	O
as	O
a	O
drug	O
model	O
and	O
loaded	O
in	O
functional	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
via	O
a	O
one	O
-	O
pot	O
procedure	O
among	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
,	O
drug	B:C1254351
,	O
and	O
lysine	O
-	O
dopamine	O
(	O
lysine	O
-	I:C0013030
dopamine	I:C0013030
)	O
under	O
basic	O
conditions	O
.	O

In	O
detail	O
,	O
RhB	O
or	O
DOX	O
was	O
used	O
as	O
a	O
drug	O
model	O
and	O
loaded	O
in	O
functional	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
via	O
a	O
one	O
-	O
pot	O
procedure	O
among	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
,	O
drug	O
,	O
and	O
lysine	B:C0024337
-	O
dopamine	O
(	O
lysine	O
-	I:C0013030
dopamine	I:C0013030
)	O
under	O
basic	O
conditions	O
.	O

In	O
detail	O
,	O
RhB	O
or	O
DOX	O
was	O
used	O
as	O
a	O
drug	O
model	O
and	O
loaded	O
in	O
functional	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
via	O
a	O
one	O
-	O
pot	O
procedure	O
among	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
,	O
drug	O
,	O
and	O
lysine	O
-	O
dopamine	B:C0013030
(	O
lysine	O
-	I:C0013030
dopamine	I:C0013030
)	O
under	O
basic	O
conditions	O
.	O

In	O
detail	O
,	O
RhB	O
or	O
DOX	O
was	O
used	O
as	O
a	O
drug	O
model	O
and	O
loaded	O
in	O
functional	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
via	O
a	O
one	O
-	O
pot	O
procedure	O
among	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
,	O
drug	O
,	O
and	O
lysine	O
-	O
dopamine	O
(	O
lysine	B:C0013030
-	I:C0013030
dopamine	I:C0013030
)	O
under	O
basic	O
conditions	O
.	O

In	O
detail	O
,	O
RhB	O
or	O
DOX	O
was	O
used	O
as	O
a	O
drug	O
model	O
and	O
loaded	O
in	O
functional	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
via	O
a	O
one	O
-	O
pot	O
procedure	O
among	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
,	O
drug	O
,	O
and	O
lysine	O
-	O
dopamine	O
(	O
lysine	O
-	I:C0013030
dopamine	I:C0013030
)	O
under	O
basic	B:C0178499
conditions	O
.	O

Owing	O
to	O
the	O
fact	O
that	O
the	O
peptide	O
bonds	O
between	O
lysine	B:C0024337
and	O
dopamine	O
can	O
be	O
cleaved	O
under	O
triggering	O
by	O
pepsin	O
,	O
the	O
resulting	O
RhB	O
/	O
DOX	O
@	O
polylysine	O
-	I:C0013030
dopamine	I:C0013030
-	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
exibit	O
enzyme	O
-	O
responsive	O
characterization	O
.	O

Owing	O
to	O
the	O
fact	O
that	O
the	O
peptide	O
bonds	O
between	O
lysine	O
and	O
dopamine	B:C0013030
can	O
be	O
cleaved	O
under	O
triggering	O
by	O
pepsin	O
,	O
the	O
resulting	O
RhB	O
/	O
DOX	O
@	O
polylysine	O
-	I:C0013030
dopamine	I:C0013030
-	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
exibit	O
enzyme	O
-	O
responsive	O
characterization	O
.	O

Owing	O
to	O
the	O
fact	O
that	O
the	O
peptide	O
bonds	O
between	O
lysine	O
and	O
dopamine	O
can	O
be	O
cleaved	O
under	O
triggering	O
by	O
pepsin	B:C0030909
,	O
the	O
resulting	O
RhB	O
/	O
DOX	O
@	O
polylysine	O
-	I:C0013030
dopamine	I:C0013030
-	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
exibit	O
enzyme	O
-	O
responsive	O
characterization	O
.	O

Owing	O
to	O
the	O
fact	O
that	O
the	O
peptide	O
bonds	O
between	O
lysine	O
and	O
dopamine	O
can	O
be	O
cleaved	O
under	O
triggering	O
by	O
pepsin	O
,	O
the	O
resulting	O
RhB	B:C0073194
/	O
DOX	O
@	O
polylysine	O
-	I:C0013030
dopamine	I:C0013030
-	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
exibit	O
enzyme	O
-	O
responsive	O
characterization	O
.	O

Owing	O
to	O
the	O
fact	O
that	O
the	O
peptide	O
bonds	O
between	O
lysine	O
and	O
dopamine	O
can	O
be	O
cleaved	O
under	O
triggering	O
by	O
pepsin	O
,	O
the	O
resulting	O
RhB	O
/	O
DOX	B:C0013089
@	O
polylysine	O
-	I:C0013030
dopamine	I:C0013030
-	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
exibit	O
enzyme	O
-	O
responsive	O
characterization	O
.	O

Owing	O
to	O
the	O
fact	O
that	O
the	O
peptide	O
bonds	O
between	O
lysine	O
and	O
dopamine	O
can	O
be	O
cleaved	O
under	O
triggering	O
by	O
pepsin	O
,	O
the	O
resulting	O
RhB	O
/	O
DOX	O
@	O
polylysine	B:C0013030
-	I:C0013030
dopamine	I:C0013030
-	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
exibit	O
enzyme	O
-	O
responsive	O
characterization	O
.	O

Owing	O
to	O
the	O
fact	O
that	O
the	O
peptide	O
bonds	O
between	O
lysine	O
and	O
dopamine	O
can	O
be	O
cleaved	O
under	O
triggering	O
by	O
pepsin	O
,	O
the	O
resulting	O
RhB	O
/	O
DOX	O
@	O
polylysine	O
-	I:C0013030
dopamine	I:C0013030
-	O
mesoporous	B:C0037098
silica	I:C0037098
nanoparticles	I:C0037098
exibit	O
enzyme	O
-	O
responsive	O
characterization	O
.	O

Owing	O
to	O
the	O
fact	O
that	O
the	O
peptide	O
bonds	O
between	O
lysine	O
and	O
dopamine	O
can	O
be	O
cleaved	O
under	O
triggering	O
by	O
pepsin	O
,	O
the	O
resulting	O
RhB	O
/	O
DOX	O
@	O
polylysine	O
-	I:C0013030
dopamine	I:C0013030
-	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
exibit	O
enzyme	B:C0014442
-	O
responsive	O
characterization	O
.	O

After	O
the	O
DOX	B:C0013089
@	O
polylysine	O
-	I:C0013030
dopamine	I:C0013030
-	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
enter	O
into	O
the	O
cancer	O
cells	I:C0334227
,	O
the	O
drug	O
can	O
be	O
released	O
effectively	O
through	O
degradation	O
of	I:C0597304
peptide	I:C0597304
bonds	I:C0597304
under	O
the	O
influence	O
of	O
enzyme	O
in	O
cancer	O
cells	I:C0334227
,	O
which	O
shows	O
marked	O
anticancer	O
activity	O
in	O
vitro	O
.	O

After	O
the	O
DOX	O
@	O
polylysine	B:C0013030
-	I:C0013030
dopamine	I:C0013030
-	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
enter	O
into	O
the	O
cancer	O
cells	I:C0334227
,	O
the	O
drug	O
can	O
be	O
released	O
effectively	O
through	O
degradation	O
of	I:C0597304
peptide	I:C0597304
bonds	I:C0597304
under	O
the	O
influence	O
of	O
enzyme	O
in	O
cancer	O
cells	I:C0334227
,	O
which	O
shows	O
marked	O
anticancer	O
activity	O
in	O
vitro	O
.	O

After	O
the	O
DOX	O
@	O
polylysine	O
-	I:C0013030
dopamine	I:C0013030
-	O
mesoporous	B:C0037098
silica	I:C0037098
nanoparticles	I:C0037098
enter	O
into	O
the	O
cancer	O
cells	I:C0334227
,	O
the	O
drug	O
can	O
be	O
released	O
effectively	O
through	O
degradation	O
of	I:C0597304
peptide	I:C0597304
bonds	I:C0597304
under	O
the	O
influence	O
of	O
enzyme	O
in	O
cancer	O
cells	I:C0334227
,	O
which	O
shows	O
marked	O
anticancer	O
activity	O
in	O
vitro	O
.	O

After	O
the	O
DOX	O
@	O
polylysine	O
-	I:C0013030
dopamine	I:C0013030
-	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
enter	O
into	O
the	O
cancer	B:C0334227
cells	I:C0334227
,	O
the	O
drug	O
can	O
be	O
released	O
effectively	O
through	O
degradation	O
of	I:C0597304
peptide	I:C0597304
bonds	I:C0597304
under	O
the	O
influence	O
of	O
enzyme	O
in	O
cancer	O
cells	I:C0334227
,	O
which	O
shows	O
marked	O
anticancer	O
activity	O
in	O
vitro	O
.	O

After	O
the	O
DOX	O
@	O
polylysine	O
-	I:C0013030
dopamine	I:C0013030
-	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
enter	O
into	O
the	O
cancer	O
cells	I:C0334227
,	O
the	O
drug	B:C1254351
can	O
be	O
released	O
effectively	O
through	O
degradation	O
of	I:C0597304
peptide	I:C0597304
bonds	I:C0597304
under	O
the	O
influence	O
of	O
enzyme	O
in	O
cancer	O
cells	I:C0334227
,	O
which	O
shows	O
marked	O
anticancer	O
activity	O
in	O
vitro	O
.	O

After	O
the	O
DOX	O
@	O
polylysine	O
-	I:C0013030
dopamine	I:C0013030
-	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
enter	O
into	O
the	O
cancer	O
cells	I:C0334227
,	O
the	O
drug	O
can	O
be	O
released	O
effectively	O
through	O
degradation	B:C0597304
of	I:C0597304
peptide	I:C0597304
bonds	I:C0597304
under	O
the	O
influence	O
of	O
enzyme	O
in	O
cancer	O
cells	I:C0334227
,	O
which	O
shows	O
marked	O
anticancer	O
activity	O
in	O
vitro	O
.	O

After	O
the	O
DOX	O
@	O
polylysine	O
-	I:C0013030
dopamine	I:C0013030
-	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
enter	O
into	O
the	O
cancer	O
cells	I:C0334227
,	O
the	O
drug	O
can	O
be	O
released	O
effectively	O
through	O
degradation	O
of	I:C0597304
peptide	I:C0597304
bonds	I:C0597304
under	O
the	O
influence	O
of	O
enzyme	B:C0014442
in	O
cancer	O
cells	I:C0334227
,	O
which	O
shows	O
marked	O
anticancer	O
activity	O
in	O
vitro	O
.	O

After	O
the	O
DOX	O
@	O
polylysine	O
-	I:C0013030
dopamine	I:C0013030
-	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
enter	O
into	O
the	O
cancer	O
cells	I:C0334227
,	O
the	O
drug	O
can	O
be	O
released	O
effectively	O
through	O
degradation	O
of	I:C0597304
peptide	I:C0597304
bonds	I:C0597304
under	O
the	O
influence	O
of	O
enzyme	O
in	O
cancer	B:C0334227
cells	I:C0334227
,	O
which	O
shows	O
marked	O
anticancer	O
activity	O
in	O
vitro	O
.	O

After	O
the	O
DOX	O
@	O
polylysine	O
-	I:C0013030
dopamine	I:C0013030
-	O
mesoporous	O
silica	I:C0037098
nanoparticles	I:C0037098
enter	O
into	O
the	O
cancer	O
cells	I:C0334227
,	O
the	O
drug	O
can	O
be	O
released	O
effectively	O
through	O
degradation	O
of	I:C0597304
peptide	I:C0597304
bonds	I:C0597304
under	O
the	O
influence	O
of	O
enzyme	O
in	O
cancer	O
cells	I:C0334227
,	O
which	O
shows	O
marked	O
anticancer	B:C0003392
activity	O
in	O
vitro	O
.	O

This	O
facile	O
strategy	B:C0035171
may	O
provide	O
a	O
new	O
platform	O
to	O
construct	O
enzyme	O
-	O
responsive	O
controlled	O
drug	O
delivery	I:C1881966
systems	I:C1881966
.	O

This	O
facile	O
strategy	O
may	O
provide	O
a	O
new	O
platform	O
to	O
construct	O
enzyme	B:C0014442
-	O
responsive	O
controlled	O
drug	O
delivery	I:C1881966
systems	I:C1881966
.	O

This	O
facile	O
strategy	O
may	O
provide	O
a	O
new	O
platform	O
to	O
construct	O
enzyme	O
-	O
responsive	O
controlled	O
drug	B:C1881966
delivery	I:C1881966
systems	I:C1881966
.	O

